Aeterna Zentaris Inc. (NASDAQ:AEZS) price is hovering higher on Monday, Jan 04, jumping 10.43% above its previous close.
A look at today’s price movement shows that the recent level at last check reads $0.43, with intraday deals fluctuating between $0.4200 and $0.4888. The company’s 5Y monthly beta was ticking 2.11 while its P/E ratio in the trailing 12-month period read 0. Taking into account the 52-week price action we note that the stock hit a 52-week high of $1.54 and 52-week low of $0.29. The stock added 7.72% on its value in the past month.
On the technical perspective front, indicators give AEZS a short term outlook of 50% Buy on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Sell, while an average of long term indicators are currently assigning the stock as 50% Sell.
Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. Specifically, 1 analysts have assigned AEZS a recommendation rating as follows: None rate it as a Hold; 1 advise Buy while none analyst(s) assign an Outperform rating. None analyst(s) have tagged the Aeterna Zentaris Inc. (AEZS) stock as Underperform, with none recommending Sell. In general, analysts have rated the stock Buy, a scenario likely to bolster investors out for an opportunity to add to their holdings of the company’s shares.
If we dive deeper into the stock’s performance we see the positive picture represented by the PEG ratio, currently standing at 0. The overview shows that AEZS’s price is at present 18.45% off the SMA20 and 26.96% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 65.81, with weekly volatility standing at 9.09%. The indicator jumps to 9.34% when calculated based on the past 30 days. Aeterna Zentaris Inc. (NASDAQ:AEZS)’s beta value is holding at 2.11, while the average true range (ATR) indicator is currently reading 0.04. Considering analysts have assigned the stock a price target range of $4.5-$4.5 as the low and high respectively, we find the trailing 12-month average consensus price target to be $4.5. Based on this estimate, we see that today’s price at last check is roughly 857.45% off the estimated low and 857.45% off the forecast high. Investors will no doubt be excited to see the share price rise to $4.5, which is the median consensus price, and at that level AEZS would be +857.45% from recent price.
Turning out attention to how the Aeterna Zentaris Inc. stock has performed in comparison to its peers in the industry, here’s what we find: AEZS’s stock is +10.43% on the day and -51.73% in the past 12 months, while Bristol-Myers Squibb Company (BMY) traded -1.71% in the latest session and is positioned -2.07% down on its price 12 months ago. Another comparison is with Amgen Inc (AMGN) whose stock price is down -1.64% in the current trading session, but has tanked -4.24% over the past year. Also, Gilead Sciences Inc (GILD) is currently showing uptrend of 10.43% while its price kept floating at -51.73% over the past year. As for Aeterna Zentaris Inc., the P/E ratio stands at 0 lower than that of Bristol-Myers Squibb Company’s at 0 and Amgen Inc’s 18.54. Elsewhere in the market, the S&P 500 Index has fell -1.61% in today’s early trading, with the Dow Jones Industrial also seeing a negative session so far with -1.78%.
An analysis of the Aeterna Zentaris Inc. (NASDAQ:AEZS) stock in terms of its daily trading volume indicates that the 3-month average is 2.26 Million. However, this figure increases on the past 10-day timeline to an average of 2.69 Million.
Curent records show that the company has 62.68 Million in outstanding shares. According to data from Thomson Reuters, insiders’ percentage holdings are 6.29% of outstanding shares while the percentage share held by institutions stands at 4.44%. The stats also highlight that short interest as of December 14, 2020, stood at 1.89 Million shares, which puts the short ratio at the time at 0.5. From this we can glean that short interest is 3.01% of company’s current outstanding shares. Notably, we see that shares short in December fell slightly given the previous month’s figure stood at 772.7 Million. But the -53.24% downside, the stock’s price has registered year-to-date as of today’s value, will likely reignite investor interest given the prospect of it rallying higher ahead.
Even if you’re not actively in crypto, you deserve to know what’s actually going on..
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets are already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.